Dermavant to Present New ADORING Data Including Treatment of Patients with Skin of Color from Phase 3 Trials of VTAMA® (tapinarof) Cream, 1% in Adults and Children 2 Years of Age and Older with Atopic Dermatitis at the 2024 AAD Annual Meeting

March 1, 2024 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Dermavant to Present New ADORING Data Including Treatment of Patients with Skin of Color from Phase 3 Trials of VTAMA® (tapinarof) Cream, 1% in Adults and Children 2 Years of Age and Older with Atopic Dermatitis at the 2024 AAD Annual Meeting

LONG BEACH, Calif. & BASEL, Switzerland–(BUSINESS WIRE)–Dermavant to Present New ADORING Data at the 2024 American Academy of Dermatology Annual Meeting
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks